Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Akagi

Showing results (81-90 of 261) with videos related to

Pageof 27
Sort By:
Anticancer Research|August 30, 2011
Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosisTakefumi Yoshida, Tetsushi Kinugasa, Yoshito Akagi, et al.
BMC Cancer|January 10, 2018
Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapyHiroshi Saeki, Yasunori Emi, Eiji Oki, et al.
Breast Cancer (Tokyo, Japan)|January 10, 2021
ER staining levels affect HER2 staining and heterogeneityMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
The Kurume Medical Journal|March 18, 2017
Successful Resection of a Large Rectal Adenoma Using the Transsacral ApproachTakuya Horio, Yosuke Oka, Ichitaro Shiratsuchi, et al.
Anticancer Research|July 14, 2015
Analysis of Wnt and β-catenin Expression in Advanced Colorectal CancerNaohiro Yoshida, Tetsushi Kinugasa, Koichi Ohshima, et al.
The Annals of Thoracic Surgery|January 23, 2016
Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in ThymomaShintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi, et al.
Journal of Gastroenterology and Hepatology|May 24, 2023
High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapyToshimitsu Tanaka, Keisuke Miwa, Yasutaka Shimotsuura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma]Yutaro Mihara, Keizo Yamaguchi, Takekuni Nakama, et al.
Anticancer Research|June 20, 2013
Gemcitabine with paclitaxel therapy against mesocolic leiomyosarcoma: a case reportTomoaki Mizobe, Yoshito Akagi, Hiroto Ishikawa, et al.
Anticancer Research|July 27, 2022
Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged LiverNobuhisa Shirahama, Yuichi Goto, Hisamune Sakai, et al.
Pageof 27

Showing results (81-90 of 261) with videos related to

Sort By:
Pageof 27
Anticancer Research|August 30, 2011
Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosisTakefumi Yoshida, Tetsushi Kinugasa, Yoshito Akagi, et al.
BMC Cancer|January 10, 2018
Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapyHiroshi Saeki, Yasunori Emi, Eiji Oki, et al.
Breast Cancer (Tokyo, Japan)|January 10, 2021
ER staining levels affect HER2 staining and heterogeneityMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
The Kurume Medical Journal|March 18, 2017
Successful Resection of a Large Rectal Adenoma Using the Transsacral ApproachTakuya Horio, Yosuke Oka, Ichitaro Shiratsuchi, et al.
Anticancer Research|July 14, 2015
Analysis of Wnt and β-catenin Expression in Advanced Colorectal CancerNaohiro Yoshida, Tetsushi Kinugasa, Koichi Ohshima, et al.
The Annals of Thoracic Surgery|January 23, 2016
Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in ThymomaShintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi, et al.
Journal of Gastroenterology and Hepatology|May 24, 2023
High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapyToshimitsu Tanaka, Keisuke Miwa, Yasutaka Shimotsuura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma]Yutaro Mihara, Keizo Yamaguchi, Takekuni Nakama, et al.
Anticancer Research|June 20, 2013
Gemcitabine with paclitaxel therapy against mesocolic leiomyosarcoma: a case reportTomoaki Mizobe, Yoshito Akagi, Hiroto Ishikawa, et al.
Anticancer Research|July 27, 2022
Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged LiverNobuhisa Shirahama, Yuichi Goto, Hisamune Sakai, et al.
Pageof 27